QNTM Quantum BioPharma Ltd.
Company Analysis
Latest News
🔴 Quantum BioPharma Ltd. is trading 3.2% down today after FDA clinical hold on Lucid-MS
Quantum BioPharma Ltd. is trading 3.2% down today at $5.08, extending a steep multi-day slide following last week’s double-digit declines. • The U.S. FDA has...
Quantum BioPharma Withdraws Lucid-MS Timelines, Citing FDA Clinical Hold
The U.S. Food and Drug Administration (FDA) placed a clinical hold on Quantum BioPharma Ltd.’s Investigational New Drug (IND) application for Lucid-MS. This...
🔴 Quantum BioPharma Ltd. is trading 14.2% down today as liquidity and financing concerns fuel post-Q1 sell-off
Quantum BioPharma Ltd. is trading 14.2% down at $5.88 as investors extend a heavy sell-off following the company's Q1 2026 liquidity and business update. •...
Quantum BioPharma's Stock Slides 33% in a Week — Is the Q1 Liquidity Story Enough to Justify a Floor?
Shares of Quantum BioPharma Ltd. (QNTM) sank another 9.5% to $6.21 on Monday, extending a punishing weeklong decline from $9.24 on May 22 — a cumulative drop...
🔴 Quantum BioPharma Ltd. is trading 9.5% down today as it extends a post-earnings slide
Quantum BioPharma Ltd. is trading at $6.21 (9.5% down), extending its recent slide as the market continues to digest its first-quarter 2026 update and last...